Literature DB >> 19615447

Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors.

Zsuzsanna Izsvák1, Marinee K L Chuah, Thierry Vandendriessche, Zoltán Ivics.   

Abstract

Transposable elements can be considered as natural, non-viral gene delivery vehicles capable of efficient genomic insertion. The plasmid-based transposon system of Sleeping Beauty (SB) combines the advantages of viruses and naked DNA molecules. In contrast to plasmid vectors, transposons integrate through a precise, recombinase-mediated mechanism into chromosomes, providing long-term expression of the gene of interest in cells. The advantages of transposons in comparison to viral systems include their simplicity and improved safety/toxicity profiles. In addition, the hyperactive SB100X is the first plasmid-based delivery system that overcomes the efficacy of non-viral delivery. The transposon delivery system consists of the transposase and the integration cassette, recognized by the transposase. The plasmid-based transposon delivery system can be combined with any non-viral delivery method. Here we provide two detailed protocols to apply SB-mediated, non-viral gene transfer in cultured cells. In our first example, we use a lipid-based delivery method in combination with the transposon-based integration system in an easy-to-transfect (HeLa) cell line. Second, we show how to achieve 40-50% stable expression of a transgene in clinically relevant, hard-to-transfect cells (hematopoetic stem cells, HSCs) by nucleofection. The given protocols are adaptable to any vertebrate cells in culture.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615447     DOI: 10.1016/j.ymeth.2009.07.001

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  38 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Differential sensitivities of retroviruses to integrase strand transfer inhibitors.

Authors:  Yasuhiro Koh; Kenneth A Matreyek; Alan Engelman
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  A Photo-clickable ATP-Mimetic Reveals Nucleotide Interactors in the Membrane Proteome.

Authors:  Mark Jelcic; Ke Wang; King Lam Hui; Xiao-Chuan Cai; Balázs Enyedi; Minkui Luo; Philipp Niethammer
Journal:  Cell Chem Biol       Date:  2020-06-09       Impact factor: 8.116

4.  Gene transfer into cardiac myocytes.

Authors:  Sarah E Lang; Margaret V Westfall
Journal:  Methods Mol Biol       Date:  2015

5.  Novel strategies for gene trapping and insertional mutagenesis mediated by Sleeping Beauty transposon.

Authors:  Guili Song; Zongbin Cui
Journal:  Mob Genet Elements       Date:  2013-10-02

Review 6.  Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.

Authors:  Bipulendu Jena; Gianpietro Dotti; Laurence J N Cooper
Journal:  Blood       Date:  2010-05-03       Impact factor: 22.113

Review 7.  Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells.

Authors:  Christopher B Doering; David Archer; H Trent Spencer
Journal:  Adv Drug Deliv Rev       Date:  2010-09-30       Impact factor: 15.470

Review 8.  CARs in chronic lymphocytic leukemia -- ready to drive.

Authors:  Chitra Hosing; Partow Kebriaei; William Wierda; Bipulendu Jena; Laurence J N Cooper; Elizabeth Shpall
Journal:  Curr Hematol Malig Rep       Date:  2013-03       Impact factor: 3.952

9.  The Cell Nucleus Serves as a Mechanotransducer of Tissue Damage-Induced Inflammation.

Authors:  Balázs Enyedi; Mark Jelcic; Philipp Niethammer
Journal:  Cell       Date:  2016-05-19       Impact factor: 41.582

10.  Generation of neuronal progenitor cells and neurons from mouse sleeping beauty transposon-generated induced pluripotent stem cells.

Authors:  Nuttha Klincumhom; Melinda K Pirity; Sara Berzsenyi; Olga Ujhelly; Suchitra Muenthaisong; Sasitorn Rungarunlert; Theerawat Tharasanit; Mongkol Techakumphu; Andras Dinnyes
Journal:  Cell Reprogram       Date:  2012-08-23       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.